sb 203580 has been researched along with sodium fluoride in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sodium fluoride) | Trials (sodium fluoride) | Recent Studies (post-2010) (sodium fluoride) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 7,257 | 1,007 | 1,847 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamura, H; Kozawa, O; Matsuno, H; Uematsu, T | 1 |
| Akamatsu, S; Dohi, S; Kozawa, O; Tanabe, K; Uematsu, T; Yamamoto, T | 1 |
2 other study(ies) available for sb 203580 and sodium fluoride
| Article | Year |
|---|---|
p38 MAP kinase is involved in the signalling of sphingosine in osteoblasts: sphingosine inhibits prostaglandin F(2alpha)-induced phosphoinositide hydrolysis.
Topics: Animals; Blotting, Western; Dinoprost; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Hydrolysis; Imidazoles; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Osteoblasts; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositols; Phosphorylation; Pyridines; Signal Transduction; Sodium Fluoride; Sphingosine; Time Factors | 2000 |
Enhancement by sphingosine 1-phosphate in vasopressin-induced phosphoinositide hydrolysis in aortic smooth-muscle cells: involvement of p38 MAP kinase.
Topics: Aorta; Arginine Vasopressin; Cell Line; Enzyme Inhibitors; Flavonoids; Hydrolysis; Imidazoles; Lysophospholipids; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphatidylinositols; Phosphorylation; Pyridines; Sodium Fluoride; Sphingosine; Tumor Necrosis Factor-alpha; Virulence Factors, Bordetella | 2000 |